BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 12859730)

  • 1. Lactobacillus gasseri OLL2716 as a probiotic in clarithromycin-resistant Helicobacter pylori infection.
    Ushiyama A; Tanaka K; Aiba Y; Shiba T; Takagi A; Mine T; Koga Y
    J Gastroenterol Hepatol; 2003 Aug; 18(8):986-91. PubMed ID: 12859730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of detection of clarithromycin-resistant Helicobacter pylori from fecal specimens for young adults treated with eradication therapy.
    Osaki T; Mabe K; Zaman C; Yonezawa H; Okuda M; Amagai K; Fujieda S; Goto M; Shibata W; Kato M; Kamiya S
    Helicobacter; 2017 Oct; 22(5):. PubMed ID: 28544222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi locus sequence typing (MLST) used as a tool to confirm the ability of susceptible Helicobacter pylori strains to gain resistance to clarithromycin during eradication therapy.
    Skvarc M; Kofol R; Samo J; Kopitar AN; Tepes B; Ihan A
    Hepatogastroenterology; 2014; 61(129):226-31. PubMed ID: 24895826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacteriocin-like inhibitory activities of seven Lactobacillus delbrueckii subsp. bulgaricus strains against antibiotic susceptible and resistant Helicobacter pylori strains.
    Boyanova L; Gergova G; Markovska R; Yordanov D; Mitov I
    Lett Appl Microbiol; 2017 Dec; 65(6):469-474. PubMed ID: 28975642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of tailored Helicobacter pylori eradication treatment based on clarithromycin susceptibility and maintenance of acid secretion.
    Sugimoto M; Uotani T; Sahara S; Ichikawa H; Yamade M; Sugimoto K; Furuta T
    Helicobacter; 2014 Aug; 19(4):312-8. PubMed ID: 24690010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An assessment of the efficacy of first-line Helicobacter pylori-eradication therapy based on clarithromycin susceptibility.
    Miyaki A; Yamaguchi K; Ida A; Miyauchi T
    Minerva Gastroenterol Dietol; 2016 Sep; 62(3):234-9. PubMed ID: 27304198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tailored eradication therapy based on fecal Helicobacter pylori clarithromycin sensitivities.
    Kawai T; Yamagishi T; Yagi K; Kataoka M; Kawakami K; Sofuni A; Itoi T; Sakai Y; Moriyasu F; Osaka Y; Takagi Y; Aoki T; Rimbara E; Noguchi N; Sasatsu M
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S171-4. PubMed ID: 19120893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are probiotics useful for therapy of Helicobacter pylori diseases?
    Eslami M; Yousefi B; Kokhaei P; Jazayeri Moghadas A; Sadighi Moghadam B; Arabkari V; Niazi Z
    Comp Immunol Microbiol Infect Dis; 2019 Jun; 64():99-108. PubMed ID: 31174707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of clarithromycin resistance on eradication of Helicobacter pylori in infected adults.
    Lee JH; Shin JH; Roe IH; Sohn SG; Lee JH; Kang GH; Lee HK; Jeong BC; Lee SH
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1600-3. PubMed ID: 15793150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antibiotic-resistant H. pylori strains in the last ten years in Japan].
    Murakami K; Kimoto M
    Nihon Rinsho; 1999 Jan; 57(1):81-6. PubMed ID: 10036940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Ameliorating Effect of Lactobacillus gasseri OLL2716 on Functional Dyspepsia in Helicobacter pylori-Uninfected Individuals: A Randomized Controlled Study.
    Ohtsu T; Takagi A; Uemura N; Inoue K; Sekino H; Kawashima A; Uchida M; Koga Y
    Digestion; 2017; 96(2):92-102. PubMed ID: 28768250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can probiotics improve efficiency and safety profile of triple Helicobacter pylori eradication therapy? A prospective randomized study.
    Grgov S; Tasić T; Radovanović-Dinić B; Benedeto-Stojanov D
    Vojnosanit Pregl; 2016 Nov; 73(11):1044-9. PubMed ID: 29328644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of drugs for eradication therapy against antibiotic-resistant strains of Helicobacter pylori.
    Gotoh A; Kawakami Y; Akamatsu T; Katsuyama T
    Microbiol Immunol; 1997; 41(11):865-9. PubMed ID: 9444328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vonoprazan- vs proton-pump inhibitor-based first-line 7-day triple therapy for clarithromycin-susceptible Helicobacter pylori: A multicenter, prospective, randomized trial.
    Sue S; Ogushi M; Arima I; Kuwashima H; Nakao S; Naito M; Komatsu K; Kaneko H; Tamura T; Sasaki T; Kondo M; Shibata W; Maeda S
    Helicobacter; 2018 Apr; 23(2):e12456. PubMed ID: 29271026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sensitivity of Helicobacter pylori to amoxicillin and clarythromycin with special reference to eradication therapy].
    Tsuneoka H; Takaba M; Nagatomi Y; Mori K; Matsumoto T; Honda T
    Kansenshogaku Zasshi; 1998 Apr; 72(4):335-41. PubMed ID: 9621560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative Study of Clarithromycin- versus Metronidazole-Based Triple Therapy as First-Line Eradication for Helicobacter pylori.
    Adachi T; Matsui S; Watanabe T; Okamoto K; Okamoto A; Kono M; Yamada M; Nagai T; Komeda Y; Minaga K; Kamata K; Yamao K; Takenaka M; Asakuma Y; Sakurai T; Nishida N; Kashida H; Kudo M
    Oncology; 2017; 93 Suppl 1():15-19. PubMed ID: 29258111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a Potential Probiotic Strain Lactobacillus gasseri ATCC 33323 on Helicobacter pylori-Induced Inflammatory Response and Gene Expression in Coinfected Gastric Epithelial Cells.
    Yarmohammadi M; Yadegar A; Ebrahimi MT; Zali MR
    Probiotics Antimicrob Proteins; 2021 Jun; 13(3):751-764. PubMed ID: 33206342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved eradication rate of standard triple therapy by adding bismuth and probiotic supplement for Helicobacter pylori treatment in Thailand.
    Srinarong C; Siramolpiwat S; Wongcha-um A; Mahachai V; Vilaichone RK
    Asian Pac J Cancer Prev; 2014; 15(22):9909-13. PubMed ID: 25520127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between eradication therapy and clarithromycin-resistant Helicobacter pylori in Japan.
    Hoshiya S; Watanabe K; Tokunaga K; Tanaka A; Ninomiya H; Shingaki M; Itoh T; Saito S; Ishida H; Takahashi S
    J Gastroenterol; 2000; 35(1):10-4. PubMed ID: 10632534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Prevalence of Helicobacter pylori Resistance to Clarithromycin: a Hospital-Based Cross-Sectional Study in Nakhon Ratchasima Province, Northeast of Thailand.
    Tongtawee T; Dechsukhum C; Matrakool L; Panpimanmas S; Loyd RA; Kaewpitoon SJ; Kaewpitoon N
    Asian Pac J Cancer Prev; 2015; 16(18):8281-5. PubMed ID: 26745073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.